PANTOPRAZOLE SODIUM - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for pantoprazole sodium and what is the scope of patent protection?
Pantoprazole sodium
is the generic ingredient in four branded drugs marketed by Ajanta Pharma Ltd, Annora Pharma, Dexcel, Sun Pharm, Wyeth Pharms, Aspiro, Be Pharms, Epic Pharma Llc, Eugia Pharma, Gland Pharma Ltd, Hangzhou Zhongmei, Knack, Meitheal, Norvium Bioscience, Sandoz, Fresenius Kabi Usa, Hikma, Baxter Hlthcare Corp, Actavis Totowa, Amneal Pharms, Aurobindo Pharma Ltd, Dr Reddys Labs Ltd, Granules, Hetero Labs Ltd V, Ingenus Pharms Llc, Jubilant Generics, L Perrigo Co, Lannett Co Inc, Macleods Pharms Ltd, Mankind Pharma, Mylan Pharms Inc, Orbion Pharms, Rubicon, Sun Pharm Inds Ltd, Teva, Torrent Pharms, and Wockhardt Bio Ag, and is included in forty-one NDAs. There are four patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.Pantoprazole sodium has thirty-five patent family members in twenty-eight countries.
There are forty-eight drug master file entries for pantoprazole sodium. Seventy suppliers are listed for this compound. There are two tentative approvals for this compound.
Summary for PANTOPRAZOLE SODIUM
International Patents: | 35 |
US Patents: | 4 |
Tradenames: | 4 |
Applicants: | 37 |
NDAs: | 41 |
Drug Master File Entries: | 48 |
Finished Product Suppliers / Packagers: | 70 |
Raw Ingredient (Bulk) Api Vendors: | 67 |
Clinical Trials: | 23 |
Patent Applications: | 7,225 |
Drug Prices: | Drug price trends for PANTOPRAZOLE SODIUM |
Drug Sales Revenues: | Drug sales revenues for PANTOPRAZOLE SODIUM |
What excipients (inactive ingredients) are in PANTOPRAZOLE SODIUM? | PANTOPRAZOLE SODIUM excipients list |
DailyMed Link: | PANTOPRAZOLE SODIUM at DailyMed |
Recent Clinical Trials for PANTOPRAZOLE SODIUM
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Alexandria University | Phase 3 |
Mansoura University | Phase 1/Phase 2 |
Federal University of São Paulo | Phase 4 |
Generic filers with tentative approvals for PANTOPRAZOLE SODIUM
Applicant | Application No. | Strength | Dosage Form |
⤷ Sign Up | ⤷ Sign Up | 40MG | INJECTABLE; INJECTION |
⤷ Sign Up | ⤷ Sign Up | EQ 40MG BASE/VIAL | POWDER;INTRAVENOUS |
The 'tentative' approval signifies that the product meets all FDA standards for marketing, and, but for the patents / regulatory protections, it would approved.
Pharmacology for PANTOPRAZOLE SODIUM
Drug Class | Proton Pump Inhibitor |
Mechanism of Action | Proton Pump Inhibitors |
Anatomical Therapeutic Chemical (ATC) Classes for PANTOPRAZOLE SODIUM
Paragraph IV (Patent) Challenges for PANTOPRAZOLE SODIUM
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
PROTONIX | for Delayed-release Oral Suspension | pantoprazole sodium | 40 mg | 022020 | 1 | 2019-09-13 |
PROTONIX IV | For Injection | pantoprazole sodium | 40 mg/vial | 020988 | 1 | 2005-04-07 |
PROTONIX | Delayed-release Tablets | pantoprazole sodium | 20 mg and 40 mg | 020987 | 2004-02-02 |
US Patents and Regulatory Information for PANTOPRAZOLE SODIUM
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hangzhou Zhongmei | PANTOPRAZOLE SODIUM | pantoprazole sodium | INJECTABLE;INTRAVENOUS | 209524-001 | Aug 30, 2021 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Meitheal | PANTOPRAZOLE SODIUM | pantoprazole sodium | INJECTABLE;INTRAVENOUS | 215860-001 | Aug 29, 2022 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Dr Reddys Labs Ltd | PANTOPRAZOLE SODIUM | pantoprazole sodium | TABLET, DELAYED RELEASE;ORAL | 077619-002 | Jan 19, 2011 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Hetero Labs Ltd V | PANTOPRAZOLE SODIUM | pantoprazole sodium | TABLET, DELAYED RELEASE;ORAL | 202882-002 | Sep 10, 2014 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for PANTOPRAZOLE SODIUM
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Wyeth Pharms | PROTONIX | pantoprazole sodium | TABLET, DELAYED RELEASE;ORAL | 020987-001 | Feb 2, 2000 | ⤷ Sign Up | ⤷ Sign Up |
Wyeth Pharms | PROTONIX | pantoprazole sodium | FOR SUSPENSION, DELAYED RELEASE;ORAL | 022020-001 | Nov 14, 2007 | ⤷ Sign Up | ⤷ Sign Up |
Wyeth Pharms | PROTONIX | pantoprazole sodium | TABLET, DELAYED RELEASE;ORAL | 020987-001 | Feb 2, 2000 | ⤷ Sign Up | ⤷ Sign Up |
Wyeth Pharms | PROTONIX IV | pantoprazole sodium | INJECTABLE;INTRAVENOUS | 020988-001 | Mar 22, 2001 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for PANTOPRAZOLE SODIUM
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Guatemala | 200400194 | FORMULACIONES DE MULTIPARTICULAS DE PANTOPRAZOL. | ⤷ Sign Up |
Russian Federation | 2006114690 | СОСТАВЫ ПАНТОПРАЗОЛА, СОСТОЯЩИЕ ИЗ МНОЖЕСТВА ЧАСТИЦ | ⤷ Sign Up |
Taiwan | I372066 | ⤷ Sign Up | |
Mexico | 266708 | FORMULACIONES DE MICROPARTICULAS DE PANTOPRAZOL. | ⤷ Sign Up |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for PANTOPRAZOLE SODIUM
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0166287 | 96C0032 | Belgium | ⤷ Sign Up | PRODUCT NAME: PANTOPRAZOL. NATR. SESQUIHYDRAS PANTOPRAZOLE; NAT. REGISTRATION NO/DATE: 127 IS 98 F 3 19960222; FIRST REGISTRATION: SE 12131 19940506 |
0166287 | SPC/GB96/056 | United Kingdom | ⤷ Sign Up | PRODUCT NAME: PANTOPRAZOLE AND ITS SALTS, HYDRATES AND HYDRATES OF ITS SALTS; REGISTERED: SE SE12131 19940506; UK 04889/0010 19960604 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.